
Published On: Jul 2023
Published On: Jul 2023
According to the Business Market Insights’ research, the North America biosafety cabinet market was valued at US$ 144.43 million in 2023 and is expected to reach US$ 205.16 million by 2028, registering a CAGR of 7.3% from 2023 to 2028. Rising prevalence of infectious diseases and rising strategic initiatives are the critical factors attributed to the North America biosafety cabinet market expansion.
Infectious diseases are rapidly increasing across the region. The World Health Organization reported that infectious diseases are likely to cause millions of deaths each year. Additionally, the ease of international travel has led to an additional layer of complexity in terms of tackling with the infectious diseases which led to the pandemic conditions. Moreover, changing climatic conditions on a global level have contributed to the prevalence of infectious diseases as it can increase the severity of the infectious diseases. As per United Nations Office for Disaster Risk Reduction (UNDDR), climate change can intensify the infectious diseases encountered by humans by 58%. Since the 1970s, about 40 infectious diseases have been discovered, including SARS, MERS, Ebola virus disease, chikungunya, avian flu, swine flu, zika virus infection, and most recently, COVID-19. Antibiotic techniques such as vaccinations against influenza help reduce the illness by 17% and medical visits and hospitalizations by 18% and 19%, respectively. Patient samples are collected to conduct a vast number of experiments and studies for formulating anti-dotes and vaccines to curb infectious diseases. Additionally, appropriate care and management of these samples require a suitable workstation and sanitized environment. These controlled and disinfected environments are mostly possible with the use of biological safety cabinets, which propels the growth of the North America biosafety cabinet market.
On the contrary, high cost and maintenance of biosafety cabinets hurdles the growth of North America biosafety cabinet market.
Based on products handled, the North America biosafety cabinet market is bifurcated into biological products and toxic products. The biological products segment held 83.3% share of North America biosafety cabinet market in 2023, amassing US$ 120.30 million. It is projected to garner US$ 166.88 million by 2028 to expand at 6.8% CAGR during 2023–2028.
Based on category, the North America biosafety cabinet market is segmented into work trays, side panel construction, and accessories. The work trays segment held 56.5% share of North America biosafety cabinet market in 2023, amassing US$ 81.58 million. It is projected to garner US$ 119.38 million by 2028 to expand at 7.9% CAGR during 2023–2028.
Based on type, the North America biosafety cabinet market is segmented into class I biosafety cabinet, class II type A2 & class II type B1, class II type B2 biosafety cabinet, class II biosafety cabinet, customized cabinets, and others. The class II type A2 & class II type B1 segment held 71.8% share of North America biosafety cabinet market in 2023, amassing US$ 103.76 million. It is projected to garner US$ 150.87 million by 2028 to expand at 7.8% CAGR during 2023–2028.
Based on application, the North America biosafety cabinet market is segmented into medical health, disease prevention, food safety, biological pharmacy, environment monitoring, and others. The disease prevention segment held 50.3% share of North America biosafety cabinet market in 2023, amassing US$ 72.62 million. It is projected to garner US$ 103.35 million by 2028 to expand at 7.3% CAGR during 2023–2028.
Based on end user, the North America biosafety cabinet market is segmented into academic centers, biotech & pharmaceutical companies, microbiology centers, research & development centers, hospitals & clinics, diagnostic laboratories, and others. The biotech & pharmaceutical companies segment held 46.5% share of North America biosafety cabinet market in 2023, amassing US$ 67.13 million. It is projected to garner US$ 98.07 million by 2028 to expand at 7.9% CAGR during 2023–2028.
Based on country, the North America biosafety cabinet market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 84.7% market share in 2023. It was assessed at US$ 122.28 million in 2023 and is likely to hit US$ 172.56 million by 2028, exhibiting a CAGR of 7.1% during the forecast period.
Key players dominating the North America biosafety cabinet market are ACMAS Technologies, Biobase Biodusty Co Ltd, Esco Group of Companies, Haier Biomedical, Kewaunee Scientific Corp, Labconco Corp, NuAire Inc, and Thermo Fisher Scientific Inc among others.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com